help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agostini, C.
Right arrow Articles by Semenzato, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agostini, C.
Right arrow Articles by Semenzato, G.
(American Journal of Pathology. 2001;158:1703-1711.)
© 2001 American Society for Investigative Pathology

Regular Articles

CXCR3 and Its Ligand CXCL10 Are Expressed by Inflammatory Cells Infiltrating Lung Allografts and Mediate Chemotaxis of T Cells at Sites of Rejection

Carlo Agostini*, Fiorella Calabrese{dagger}, Federico Rea{ddagger}, Monica Facco*, Alicia Tosoni*, Monica Loy{ddagger}, Gianni Binotto*, Marialuisa Valente{dagger}, Livio Trentin* and Gianpietro Semenzato*

From the Departments of Clinical and Experimental Medicine,*
Clinical Immunology Branch, Pathology,{dagger}
and Thoracic Surgery,{ddagger}
Padua University School of Medicine, Padua, Italy

The attraction of T lymphocytes into the pulmonary parenchyma represents an essential step in mechanisms ultimately leading to lung allograft rejection. In this study we evaluated whether IP-10 (CXCL10), a chemokine that is induced by interferon-{gamma} and stimulates the directional migration of activated T cells, plays a role in regulating the trafficking of effector T cells during lung allograft rejection episodes. Immunohistochemical examination showed that areas characterized by acute cellular rejection (grades 1 to 4) and active obliterative bronchiolitis (chronic rejection, Ca) were infiltrated by T cells expressing CXCR3, ie, the specific receptor for CXCL10. In parallel, T cells accumulating in the bronchoalveolar lavage of lung transplant recipients with rejection episodes were CXCR3+ and exhibited a strong in vitro migratory capability in response to CXCL10. In lung biopsies, CXCL10 was abundantly expressed by graft-infiltrating macrophages and occasionally by epithelial cells. Alveolar macrophages expressed and secreted definite levels of CXCL10 capable of inducing chemotaxis of the CXCR3+ T-cell line 300-19; the secretory capability of alveolar macrophages was up-regulated by preincubation with interferon-{gamma}. Interestingly, striking levels of CXCR3 ligands could be demonstrated in the fluid component of the bronchoalveolar lavage in individuals with rejection episodes. These data indicate the role of the CXCR3/CXCL10 interactions in the recruitment of lymphocytes at sites of lung rejection and provide a rationale for the use of agents that block the CXCR3/CXCL10 axis in the treatment of lung allograft rejection.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. Kwun, H. Hu, E. Schadde, D. Roenneburg, K. A. Sullivan, J. DeMartino, W. J. Burlingham, and S. J. Knechtle
Altered Distribution of H60 Minor H Antigen-Specific CD8 T Cells and Attenuated Chronic Vasculopathy in Minor Histocompatibility Antigen Mismatched Heart Transplantation in Cxcr3 / Mouse Recipients
J. Immunol., December 15, 2007; 179(12): 8016 - 8025.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani
Role of Chemokines in Endocrine Autoimmune Diseases
Endocr. Rev., August 1, 2007; 28(5): 492 - 520.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
C Monteagudo, J M Martin, E Jorda, and A Llombart-Bosch
CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors
J. Clin. Pathol., June 1, 2007; 60(6): 596 - 599.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. D. Chakravarty, J. Xu, B. Lu, C. Gerard, J. Flynn, and J. Chan
The Chemokine Receptor CXCR3 Attenuates the Control of Chronic Mycobacterium tuberculosis Infection in BALB/c Mice
J. Immunol., February 1, 2007; 178(3): 1723 - 1735.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. N. Stiles, J. L. Hardison, C. S. Schaumburg, L. M. Whitman, and T. E. Lane
T Cell Antiviral Effector Function Is Not Dependent on CXCL10 Following Murine Coronavirus Infection
J. Immunol., December 15, 2006; 177(12): 8372 - 8380.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. A. Colvin, G. S. V. Campanella, L. A. Manice, and A. D. Luster
CXCR3 Requires Tyrosine Sulfation for Ligand Binding and a Second Extracellular Loop Arginine Residue for Ligand-Induced Chemotaxis
Mol. Cell. Biol., August 1, 2006; 26(15): 5838 - 5849.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. D. Medoff, J. C. Wain, E. Seung, R. Jackobek, T. K. Means, L. C. Ginns, J. M. Farber, and A. D. Luster
CXCR3 and Its Ligands in a Murine Model of Obliterative Bronchiolitis: Regulation and Function.
J. Immunol., June 1, 2006; 176(11): 7087 - 7095.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
U. Hoffmann, S. Segerer, P. Rummele, B. Kruger, M. Pietrzyk, F. Hofstadter, B. Banas, and B. K. Kramer
Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1373 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Sfriso, F. Oliviero, F. Calabrese, M. Miorin, M. Facco, A. Contri, A. Cabrelle, I. Baesso, F. Cozzi, M. Andretta, et al.
Epithelial CXCR3-B Regulates Chemokines Bioavailability in Normal, but Not in Sjogren's Syndrome, Salivary Glands
J. Immunol., February 15, 2006; 176(4): 2581 - 2589.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
X. Zeng, T. A. Moore, M. W. Newstead, J. C. Deng, S. L. Kunkel, A. D. Luster, and T. J. Standiford
Interferon-Inducible Protein 10, but Not Monokine Induced by Gamma Interferon, Promotes Protective Type 1 Immunity in Murine Klebsiella pneumoniae Pneumonia
Infect. Immun., December 1, 2005; 73(12): 8226 - 8236.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
B. D. MEDOFF, S. Y. THOMAS, A. BANERJI, J. C. WAIN, H. ZHANG, C. M. LILLY, L. C. GINNS, and A. D. LUSTER
Pathogenic T-Cell Recruitment into the Airway in Human Disease
Ann. N.Y. Acad. Sci., December 1, 2005; 1062(1): 220 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. Agostini, A. Cabrelle, F. Calabrese, M. Bortoli, E. Scquizzato, S. Carraro, M. Miorin, B. Beghe, L. Trentin, R. Zambello, et al.
Role for CXCR6 and Its Ligand CXCL16 in the Pathogenesis of T-Cell Alveolitis in Sarcoidosis
Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1290 - 1298.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Kouroumalis, R. J. Nibbs, H. Aptel, K. L. Wright, G. Kolios, and S. G. Ward
The Chemokines CXCL9, CXCL10, and CXCL11 Differentially Stimulate G{alpha}i-Independent Signaling and Actin Responses in Human Intestinal Myofibroblasts
J. Immunol., October 15, 2005; 175(8): 5403 - 5411.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
B. D. Medoff, E. Seung, J. C. Wain, T. K. Means, G. S.V. Campanella, S. A. Islam, S. Y. Thomas, L. C. Ginns, N. Grabie, A. H. Lichtman, et al.
BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation
J. Exp. Med., July 5, 2005; 202(1): 97 - 110.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. E. Heise, A. Pahuja, S. C. Hudson, M. S. Mistry, A. L. Putnam, M. M. Gross, P. A. Gottlieb, W. S. Wade, M. Kiankarimi, D. Schwarz, et al.
Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1263 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
I. A. Hauser, S. Spiegler, E. Kiss, S. Gauer, O. Sichler, E. H. Scheuermann, H. Ackermann, J. M. Pfeilschifter, H. Geiger, H.-J. Grone, et al.
Prediction of Acute Renal Allograft Rejection by Urinary Monokine Induced by IFN-{gamma} (MIG)
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1849 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Murakawa, M. M. Kerklo, M. R. Zamora, Y. Wei, R. G. Gill, P. M. Henson, F. L. Grover, and M. R. Nicolls
Simultaneous LFA-1 and CD40 Ligand Antagonism Prevents Airway Remodeling in Orthotopic Airway Transplantation: Implications for the Role of Respiratory Epithelium as a Modulator of Fibrosis
J. Immunol., April 1, 2005; 174(7): 3869 - 3879.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. G. Kelsen, M. O. Aksoy, Y. Yang, S. Shahabuddin, J. Litvin, F. Safadi, and T. J. Rogers
The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells
Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L584 - L591.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. C. Hildebrandt, L. A. Corrion, K. M. Olkiewicz, B. Lu, K. Lowler, U. A. Duffner, B. B. Moore, W. A. Kuziel, C. Liu, and K. R. Cooke
Blockade of CXCR3 Receptor:Ligand Interactions Reduces Leukocyte Recruitment to the Lung and the Severity of Experimental Idiopathic Pneumonia Syndrome
J. Immunol., August 1, 2004; 173(3): 2050 - 2059.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. M. Richards, S. L. Dalheimer, M. I. Hertz, and D. L. Mueller
Trachea Allograft Class I Molecules Directly Activate and Retain CD8+ T Cells That Cause Obliterative Airways Disease
J. Immunol., December 15, 2003; 171(12): 6919 - 6928.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Belperio, M. P. Keane, M. D. Burdick, J. P. Lynch III, D. A. Zisman, Y. Y. Xue, K. Li, A. Ardehali, D. J. Ross, and R. M. Strieter
Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection
J. Immunol., November 1, 2003; 171(9): 4844 - 4852.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Johnston, C. H. Kim, D. Soler, M. Emoto, and E. C. Butcher
Differential Chemokine Responses and Homing Patterns of Murine TCR{alpha}{beta} NKT Cell Subsets
J. Immunol., September 15, 2003; 171(6): 2960 - 2969.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Jiankuo, W. Xingbing, H. Baojun, W. Xiongwin, L. Zhuoya, X. Ping, X. Yong, L. Anting, H. Chunsong, G. Feili, et al.
Peptide Nucleic Acid Antisense Prolongs Skin Allograft Survival by Means of Blockade of CXCR3 Expression Directing T Cells into Graft
J. Immunol., February 1, 2003; 170(3): 1556 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
K. Minamoto and D. J. Pinsky
Recipient iNOS but Not eNOS Deficiency Reduces Luminal Narrowing in Tracheal Allografts
J. Exp. Med., November 18, 2002; 196(10): 1321 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
N. G. Inston and P. Cockwell
The evolving role of chemokines and their receptors in acute allograft rejection
Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1374 - 1379.
[Full Text] [PDF]

Home page
 DiabetesHome page
R. Abdi, R. N. Smith, L. Makhlouf, N. Najafian, A. D. Luster, H. Auchincloss Jr., and M. H. Sayegh
The Role of CC Chemokine Receptor 5 (CCR5) in Islet Allograft Rejection
Diabetes, August 1, 2002; 51(8): 2489 - 2495.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Belperio, M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, K. Li, D. J. Ross, and R. M. Strieter
Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome
J. Immunol., July 15, 2002; 169(2): 1037 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Dufour, M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster
IFN-{gamma}-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking
J. Immunol., April 1, 2002; 168(7): 3195 - 3204.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.